Notably, PD-1 expression on tumor-infiltrating lymphocytes was seen in 46% of GBM tumors using the cutoff of 1/high power field, and PD-L1 expression on cancer cells was seen in 19%, using the cutoff of 5% ([16]). Here, CD274 is linked to cancer.